Skip to main content
NIH funding notice RFA-AG-23-014

Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)

Closed on July 1, 2022.

Posted
February 22, 2022
Close date
July 1, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,455,074 in first-year total cost, median $623,867.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 ZIJ-P (J2)]11

Most frequent institutions

  1. BOSTON VA RESEARCH INSTITUTE, INC.1
  2. CORNELL UNIVERSITY1
  3. DREXEL UNIVERSITY1
  4. DUKE UNIVERSITY1
  5. JOHNS HOPKINS UNIVERSITY1
Competing awards under RFA-AG-23-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Metabolic and neural activity normalization by cerebral blood flow increase in AD/ADRD models1R01AG081931-01SCHAFFER, CHRIS BCORNELL UNIVERSITY, NY$1,170,347ZAG1
2023Pericyte control of capillary perfusion in the Alzheimer's disease brain1R01AG081840-01SHIH, ANDY YSEATTLE CHILDREN'S HOSPITAL, WA$890,037ZAG1
2023The effect of circadian rhythm disruptions on the angiogenic response to hypoperfusion in the AD brain1R01AG081841-01ARAI, KENLO, ENG H.SAKADZIC, SAVAMASSACHUSETTS GENERAL HOSPITAL, MA$775,852ZAG1
2023Using Photobiomodulation to Alleviate Brain Hypoperfusion in Alzheimer's Disease1R01AG081874-01LIN, HUNG WEN (KEVIN)ZHANG, QUANGUANGLOUISIANA STATE UNIV HSC SHREVEPORT, LA$707,320ZAG1
2023Sleep-dependent mechanisms of improving cerebral blood flow and reducing Alzheimer's disease progression by photobiomodulation with near-infrared light1R01AG081809-01GERASHCHENKO, DMITRYBOSTON VA RESEARCH INSTITUTE, INC., MA$669,096ZAG1
2023Modifying endothelial Piezo 1 function to improve brain perfusion in AD/ADRD1R01AG081942-01MARRELLI, SEAN PUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX$623,867ZAG1
2023The Role of Pericytes in Brain Hypoperfusion in Alzheimer's Disease Development1R01AG081807-01FAN, HONGKUANMEDICAL UNIVERSITY OF SOUTH CAROLINA, SC$620,701ZAG1
2023Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease1R01AG081932-01WEI, ZHILIANGJOHNS HOPKINS UNIVERSITY, MD$554,356ZAG1
2023Amyloid-β Disruption of Pericyte Control of Capillary Hemodynamics1R01AG081935-01GONZALES, ALBERT LOUISUNIVERSITY OF NEVADA RENO, NV$511,420ZAG1
2023Hypoperfusion, Hemodynamic Control Domains and Neurovascular Dysregulation in AD brain pathology1R01AG081774-01TURNER, DENNIS ALANDUKE UNIVERSITY, NC$501,400ZAG1
2023Dysregulation of glutamate transporter-dependent neurovascular coupling in Alzheimer's disease1R01AG081929-01JACKSON, JOSHUA GOODYEARDREXEL UNIVERSITY, PA$430,678ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-23-014: Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience